Cita APA (7a ed.)

(73290), D. W., (22687046), B. C., (22687049), T. W., (1818046), X. W., (38224), Y. L., (1723033), H. C., . . . (406210), H. S. (2025). Supplementary file 1_Drug combination discovery assisted by AI and untargeted metabolomics: Pamiparib and anlotinib synergistic potentiation for ovarian cancer treatment.docx.

Cita Chicago Style (17a ed.)

(73290), Dong Wang, Baiwang Chu (22687046), Tingjie Wen (22687049), Xueyu Wang (1818046), Ying Li (38224), Hanning Chen (1723033), Zhao Zhang (52732), y Hua Sun (406210). Supplementary File 1_Drug Combination Discovery Assisted by AI and Untargeted Metabolomics: Pamiparib and Anlotinib Synergistic Potentiation for Ovarian Cancer Treatment.docx. 2025.

Cita MLA (9a ed.)

(73290), Dong Wang, et al. Supplementary File 1_Drug Combination Discovery Assisted by AI and Untargeted Metabolomics: Pamiparib and Anlotinib Synergistic Potentiation for Ovarian Cancer Treatment.docx. 2025.

Precaución: Estas citas no son 100% exactas.